Helius Medical Technologies Inc
Change company Symbol lookup
Select an option...
HSDT Helius Medical Technologies Inc
APAM Artisan Partners Asset Management Inc
ELEMF Elemental Altus Royalties Corp
FBSI First Bancshares Inc (Missouri)
KGDEY Kingdee International Software Group Co Ltd
CMRA Comera Life Sciences Holdings Inc
ADI Analog Devices Inc
KEY KeyCorp
FNF Fidelity National Financial Inc
CTAQU Carney Technology Acquisition Corp. II
Go

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Health Care Equipment & Supplies | Small Cap Value
Company profile

Helius Medical Technologies, Inc. is a neurotech company focused on neurological wellness. The Company focuses on developing, licensing or acquiring non-implanted technologies targeted at reducing symptoms of neurological disease or trauma. The Company's product, Portable Neuromodulation Stimulator (PoNS), is a non-implanted medical device, inclusive of a controller and mouthpiece, which delivers mild electrical stimulation to the surface of the tongue to provide treatment of gait deficit and chronic balance deficit. PoNS is used as a short-term treatment of gait deficit due to mild-to-moderate symptoms for multiple sclerosis (MS) and is to be used as an adjunct to a supervised therapeutic exercise program in patients 22 years of age and over by prescription only. It is also used as a short-term treatment (14 weeks) of chronic balance deficit due to mild-to-moderate traumatic brain injury (mmTBI) and is to be used in conjunction with physical therapy (PoNS Therapy).

Price
Delayed
$0.2823
Day's Change
-0.0077 (-2.66%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.313
Day's Low
0.2806
Volume
(Light)

Today's volume of 552,914 shares is on pace to be much lighter than HSDT's 10-day average volume of 1,241,974 shares.

552,914

Display:

Providers:

UpdateCancel
6 providers
September 29, 2022
September 14, 2022
Helius Medical Technologies, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

EQNX::TICKER_START (NASDAQ:HSDT),(TSX:HSM), EQNX::TICKER_END Helius Medical Technologies, Inc. (Nasdaq: HSDT) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced that, effective September 13, 2022, its...(Globe Newswire)

September 06, 2022
Helius Medical Technologies to Present at Upcoming Healthcare Investor Conferences in September

EQNX::TICKER_START (NASDAQ:HSDT),(TSX:HSM), EQNX::TICKER_END Helius Medical Technologies, Inc. (Nasdaq:HSDT) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced that Dane Andreeff, President and Chief...(Globe Newswire)

August 24, 2022
Thinking about buying stock in SuperCom, Nordstrom, Avaya Holdings, Uranium Energy, or Helius Medical Technologies?

InvestorsObserver issues critical PriceWatch Alerts for SPCB, JWN, AVYA, UEC, and HSDT. https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg To see how InvestorsObserver's proprietary scoring system rates these stocks, view the...(PR Newswire)

August 23, 2022
Thinking about buying stock in Windtree Therapeutics, Helius Medical Technologies, SNDL, Xpeng, or Indonesia Energy?

InvestorsObserver issues critical PriceWatch Alerts for WINT, HSDT, SNDL, XPEV, and INDO. https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg To see how InvestorsObserver's proprietary scoring system rates these stocks, view the...(PR Newswire)

August 15, 2022
Helius Medical Technologies, Inc. Reports Second Quarter 2022 Financial Results

-- Net proceeds from August 2022 financing and cash on hand expected to fund operations through 2023 -- -- Company to host call at 4:30pm today -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) ("Helius" or the "Company"), a neurotech company...(Globe Newswire)

August 10, 2022
Helius Medical Technologies, Inc. to Release Second Quarter 2022 Financial Results on August 15, 2022

Helius Medical Technologies, Inc. (NASDAQ: HSDT) (TSX: HSM) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced that the Company will release its second quarter 2022 financial results on Monday, August...(Globe Newswire)

August 05, 2022
Thinking about buying stock in Marker Therapeutics, Helius Medical Technologies, T2 Biosystems, Missfresh, or LYFT?

InvestorsObserver issues critical PriceWatch Alerts for MRKR, HSDT, TTOO, MF, and LYFT. https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg To see how InvestorsObserver's proprietary scoring system rates these stocks, view the...(PR Newswire)

Helius Medical Technologies, Inc. Announces Pricing of $18 Million Public Offering

Helius Medical Technologies, Inc. (Nasdaq: HSDT) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced the pricing of a public offering of (i) 24,000,000 shares of its Class A common stock (or common...(Globe Newswire)

August 03, 2022
Thinking about buying stock in Applied DNA Sciences, Helius Medical Technologies, Eargo, Ping Identity, or Chembio Diagnostics?

InvestorsObserver issues critical PriceWatch Alerts for APDN, HSDT, EAR, PING, and CEMI.PING https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg To see how InvestorsObserver's proprietary scoring system rates these stocks, view the...(PR Newswire)

July 12, 2022
Helius Medical Technologies, Inc. Announces Online Training for PoNS Therapy(TM)

EQNX::TICKER_START (NASDAQ:HSDT), EQNX::TICKER_END Helius Medical Technologies, Inc. (Nasdaq:HSDT) ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced the launch of its online training module for...(Globe Newswire)

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.